Cutaneous immunocytomas: a clinicopathologic study of 26 cases

Area of Science:

• Dermatology
• Hematology
• Oncology

Background:

• Cutaneous immunocytomas are lymphoproliferative disorders characterized by monotypic plasma cells or lymphoplasmacytoid cells.
• Distinguishing between primary and secondary cutaneous immunocytomas is crucial for appropriate management and prognosis.

Purpose of the Study:

• To delineate the clinical and histological features of primary and secondary cutaneous immunocytomas.
• To identify key differences that differentiate these two entities.
• To discuss the differential diagnosis of cutaneous immunocytomas.

Main Methods:

• Retrospective analysis of clinical and histological data from 26 patients.
• Diagnosis confirmed by the presence of monotypic plasma cells or lymphoplasmacytoid cells.
• Comparison of clinical presentation, lesion localization, treatment response, and histological findings between primary and secondary cases.

Main Results:

• Primary cutaneous immunocytomas typically present as solitary, localized skin lesions on extremities, responding well to local treatment with a favorable prognosis.
• Secondary cutaneous immunocytomas often exhibit widespread skin involvement, sometimes associated with paraproteins or autoimmune diseases.
• Histologically, primary tumors show peripheral localization of monotypic cells, while secondary tumors display diffuse or dispersed infiltrates.

Conclusions:

• Primary cutaneous immunocytomas represent a distinct cutaneous lymphoma subtype with unique clinical and histological characteristics.
• Significant differences exist between primary and secondary cutaneous immunocytomas, impacting prognosis and management.
• Accurate differentiation from other cutaneous lymphoid neoplasms is essential for patient care.